The CME or FCME combination with SHE and metformin showed anti-diabetic effects by regulating insulin secretion and inhibiting hyperlipidemia and hyperglycemia, hence diminishing damage-related liver and kidney enzymes. Here, INS is linked to hyperlipidemia.